Endovascular Development AB

📍 Uppsala, Sweden🗓 Founded 2009👥 1 employees💰 Last funded 2015
Medical Equipment Manufacturing🌐 endovab.com
Website LinkedIn
Endovab's mission is to develop and provide innovative endovascular tools and techniques that improve vascular treatments through research and clinical experience. Endovab was founded in 2009 and has its head office in Stockholm and a research laboratory in Uppsala. The company’s founder and innovation lead MD, Ph.D. Krister Liungman, Head of Vascular Surgery at Uppsala University Hospital, has more than 25 years of experience in treating vascular disease. With experienced backers and a driven team, Endovab is committed to its objective of improving treatment within the field of endovascular surgery.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Endovascular Development AB?
Endovascular Development AB has 1 investors on record on gritt.io and 1 late-stage investors.
When did Endovascular Development AB last raise funding?
The most recent investment in Endovascular Development AB recorded on gritt.io was in 2015.
When was Endovascular Development AB founded?
Endovascular Development AB was founded in 2009.
What industry is Endovascular Development AB in?
Endovascular Development AB operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Endovascular Development AB based?
Endovascular Development AB is headquartered in Uppsala, Sweden.